Publicacións en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (49)

2025

  1. The CNIC polypill (Acetylsalicylic acid + Atorvastatin + Rampril) in secondary prevention of cardiovascular disease in patients with type 2 diabetes: A comparative analysis with alternative therapeutic approaches

    International Journal of Cardiology, Vol. 418

2024

  1. Dietary intake of Perfluorooctanesulfonic acid (PFOS) and glucose homeostasis parameters in a non-diabetic senior population

    Environment International, Vol. 186

  2. Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance

    Molecular Metabolism, Vol. 79

  3. Key role of activated platelets in the enhanced adhesion of circulating leucocyte-platelet aggregates to the dysfunctional endothelium in early-stage COPD

    Frontiers in Immunology, Vol. 15

  4. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  5. Recommendations on the management of severe obesity in patients with inflammatory bowel disease of the Spanish Group on Crohn's Disease and Ulcerative Colitis (GETECCU), Spanish Society of Obesity (SEEDO), Spanish Association of Surgery (AEC) and Spanish Society of Digestive Endoscopy (SEED)

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 8, pp. 906-923

  6. Targeting systemic inflammation in metabolic disorders. A therapeutic candidate for the prevention of cardiovascular diseases?

    Pharmacological Research, Vol. 200

  7. The CNIC-polypill (acetylsalicylic acid, atorvastatin, and ramipril), an effective and cost-saving secondary prevention strategy compared with other therapeutic options in patients with ischaemic heart disease

    European Heart Journal Open, Vol. 4, Núm. 2

  8. Ultrasound Cut-Off Values for Rectus Femoris for Detecting Sarcopenia in Patients with Nutritional Risk

    Nutrients, Vol. 16, Núm. 11

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Association of adiposity and its changes over time with COVID-19 risk in older adults with overweight/obesity and metabolic syndrome: a longitudinal evaluation in the PREDIMED-Plus cohort

    BMC Medicine, Vol. 21, Núm. 1

  3. Dietary Iron, Anemia Markers, Cognition, and Quality of Life in Older Community-Dwelling Subjects at High Cardiovascular Risk

    Nutrients, Vol. 15, Núm. 20

  4. Dietary intake of polychlorinated dibenzo-p-dioxins and furans, adiposity and obesity status.

    Environmental Research, Vol. 227

  5. Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))

    Nature communications

  6. Metabolomic signature and molecular profile of normal and degenerated human intervertebral disc cells

    Spine Journal, Vol. 23, Núm. 10, pp. 1549-1562

  7. Overview of Cellular and Soluble Mediators in Systemic Inflammation Associated with Non-Alcoholic Fatty Liver Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

2022

  1. Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?

    Biology, Vol. 11, Núm. 8

  2. Angiocrine polyamine production regulates adiposity

    Nature Metabolism, Vol. 4, Núm. 3, pp. 327-343

  3. Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study

    Nutrients, Vol. 14, Núm. 1

  4. Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function

    Journal of Hepatology, Vol. 76, Núm. 1, pp. 11-24